top of page

NanoScent to sign MOU for $20M in Series A round led by Dreamtech

By signing this MOU, Dreamtech is initiating a $20M funding round. Dreamtech and NanoScent strengthen their strategic partnership for healthcare innovative solutions. NanoScent is using this financial round to move faster into the development and validation stages of its unique technology for Covid-19 screening.


bottom of page